BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15956361)

  • 21. Modulation of the DNA damage response during the life cycle of human papillomaviruses.
    Anacker DC; Moody CA
    Virus Res; 2017 Mar; 231():41-49. PubMed ID: 27836727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of telomerase by human papillomaviruses.
    Galloway DA; Gewin LC; Myers H; Luo W; Grandori C; Katzenellenbogen RA; McDougall JK
    Cold Spring Harb Symp Quant Biol; 2005; 70():209-15. PubMed ID: 16869756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of HPV DNA replication using transient transfection and cell-free assays.
    Lin BY; Broker TR; Chow LT
    Methods Mol Med; 2005; 119():331-48. PubMed ID: 16353340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Physiopathology and epidemiology of HPV anogenital diseases].
    Riethmuller D
    Ann Dermatol Venereol; 2000; 127(10 Suppl):3S5-3S9. PubMed ID: 11116862
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of S100P gene in cervical carcinoma cells is independent of E7 human papillomavirus oncogene.
    Jakubícková L; Baráthová M; Pastoreková S; Pastorek J; Gibadulinová A
    Acta Virol; 2005; 49(2):133-7. PubMed ID: 16047742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomaviruses and the interferon response.
    Beglin M; Melar-New M; Laimins L
    J Interferon Cytokine Res; 2009 Sep; 29(9):629-35. PubMed ID: 19715460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling of dysplastic differentiation in cervical epithelial cells harboring human papillomavirus 16.
    Ranamukhaarachchi DG; Unger ER; Vernon SD; Lee D; Rajeevan MS
    Genomics; 2005 Jun; 85(6):727-38. PubMed ID: 15885499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
    Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
    J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
    Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4.
    Doorbar J; Foo C; Coleman N; Medcalf L; Hartley O; Prospero T; Napthine S; Sterling J; Winter G; Griffin H
    Virology; 1997 Nov; 238(1):40-52. PubMed ID: 9375007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of human papillomaviruses in differentiating epithelia.
    Longworth MS; Laimins LA
    Microbiol Mol Biol Rev; 2004 Jun; 68(2):362-72. PubMed ID: 15187189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter.
    Krüppel U; Müller-Schiffmann A; Baldus SE; Smola-Hess S; Steger G
    Virology; 2008 Jul; 377(1):151-9. PubMed ID: 18495195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The current concepts of papillomavirus infection and its role in the pathogenesis of pretumorous and tumorous processes of the cervix uteri].
    Lakatosh VP; Lazarenko LM; Lianenko LO; Dubchak VIe
    Lik Sprava; 1999 Mar; (2):22-31. PubMed ID: 10424034
    [No Abstract]   [Full Text] [Related]  

  • 35. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
    Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
    Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.
    Si-Mohamed A; Ndjoyi-Mbiguino A; Cuschieri K; Onas IN; Colombet I; Ozouaki F; Goff JL; Cubie H; Bélec L
    J Med Virol; 2005 Nov; 77(3):430-8. PubMed ID: 16173023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal papillomaviruses.
    Rector A; Van Ranst M
    Virology; 2013 Oct; 445(1-2):213-23. PubMed ID: 23711385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biology of human papillomaviruses.
    Nguyen HP; Ramírez-Fort MK; Rady PL
    Curr Probl Dermatol; 2014; 45():19-32. PubMed ID: 24643175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillomaviruses in human cancers.
    zur Hausen H
    Proc Assoc Am Physicians; 1999; 111(6):581-7. PubMed ID: 10591087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
    Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
    J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.